Skip to Content
Merck
  • Mechanism of actin-dependent activation of nucleotidyl cyclase toxins from bacterial human pathogens.

Mechanism of actin-dependent activation of nucleotidyl cyclase toxins from bacterial human pathogens.

Nature communications (2021-11-18)
Alexander Belyy, Felipe Merino, Undine Mechold, Stefan Raunser
ABSTRACT

Bacterial human pathogens secrete initially inactive nucleotidyl cyclases that become potent enzymes by binding to actin inside eukaryotic host cells. The underlying molecular mechanism of this activation is, however, unclear. Here, we report structures of ExoY from Pseudomonas aeruginosa and Vibrio vulnificus bound to their corresponding activators F-actin and profilin-G-actin. The structures reveal that in contrast to the apo-state, two flexible regions become ordered and interact strongly with actin. The specific stabilization of these regions results in an allosteric stabilization of the nucleotide binding pocket and thereby to an activation of the enzyme. Differences in the sequence and conformation of the actin-binding regions are responsible for the selective binding to either F- or G-actin. Other nucleotidyl cyclase toxins that bind to calmodulin rather than actin undergo a similar disordered-to-ordered transition during activation, suggesting that the allosteric activation-by-stabilization mechanism of ExoY is conserved in these enzymes, albeit the different activator.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Thymosin β4 human, recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC)